du Cros PAK, Greig J, Cross GB, Cousins C, Berry C, et al.
2023-12-01 • International Journal of Tuberculosis and Lung Disease
2023-12-01 • International Journal of Tuberculosis and Lung Disease
BACKGROUND The value, speed of completion and robustness of the evidence generated by TB treatment trials could be improved by implementing standards for best practice.
2013-09-29 • Transactions of the Royal Society of Tropical Medicine and Hygiene
2013-09-29 • Transactions of the Royal Society of Tropical Medicine and Hygiene
Médecins Sans Frontières (MSF) provides TB treatment in Galkayo and Marere in Somalia. MSF international supervisory staff withdrew in 2008 owing to insecurity but maintained daily commu...
Minetti A, Camelique O, Hsa Thaw K, Thi SS, Swaddiwudhipong W, et al.
2010-12-01 • International Journal of Tuberculosis and Lung Disease
2010-12-01 • International Journal of Tuberculosis and Lung Disease
SETTING Although tuberculosis (TB) is a curable disease, it remains a major global health problem and an important cause of morbidity and mortality among vulnerable populations, incl...
Mehta S, Das M, Laxmeshwar C, Jonckheere S, Thi SS, et al.
2016-09-09 • PLOS One
2016-09-09 • PLOS One
Patients on linezolid-containing drug-resistant TB (DR-TB) regimen often develop adverse-events, particularly peripheral and optic neuropathy. Programmatic data and experiences of linezo...
